SCHEMBL5676014

SCHEMBL5676014

CCOC(=O)CC1(c2ccccc2OCC)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.48
ADCY8 P40145 1/20 0.47
IDO1 P14902 2/20 0.45
CBX7 O95931 2/20 0.41
CDYL Q9Y232 2/20 0.41
CDYL2 Q8N8U2 1/20 0.41
CDY1; CDY1B Q9Y6F8 1/20 0.41
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 2/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
KCNMA1 Q12791 1/20 0.40
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5674253 0.92 BRD4 (0.48) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5674786 0.89 IDO1 (0.46) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5675856 0.89 BRD4 (0.46) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5675760 0.87 BRD4 (0.45) BRD4ADCY8MAPTL3MBTL1TSHR
SCHEMBL5674796 0.86 BRD4 (0.48) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5674413 0.85 CBX7 (0.46) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5675743 0.80 ALDH1A1 (0.47) BRD4ADCY8MEN1KMT2AGAA
SCHEMBL2494879 0.79 KMT2A (0.53) BRD4ADCY8IDO1CBX7CDYL
SCHEMBL5675808 0.78 ALDH1A1 (0.45) BRD4ADCY8L3MBTL1KMT2AGAA
SCHEMBL2492359 0.78 CBX7 (0.48) BRD4ADCY8IDO1CBX7CDYL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119086-B2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2006-10-10 US disclosed
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use AVPR2, AVPR1A, AVPR1B BRD4 2751/4885ADCY8 1986/4885IDO1 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.